Related Experiment Video
Updated: Jul 13, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Contrast medium induced nephropathy in urological practice
Simona Detrenis1, Michele Meschi, Maria del Mar Jordana Sanchez
1Department of Internal Medicine and Nephrology, University of Parma, Italy.
Insights
Contrast medium induced nephropathy is a significant cause of acute renal failure. Urological patients require proactive prevention strategies, including hydration and drug review, to mitigate risks associated with contrast media.
Area of Science:
- Nephrology
- Urology
- Radiology
Background:
- Contrast medium induced nephropathy (CMIN) is a leading cause of hospital-acquired acute renal failure.
- Historically, research on CMIN focused on urological practice, but recent attention has shifted to interventional radiology and cardiology.
- Urological patients often have pre-existing renal conditions, increasing their susceptibility to CMIN.
Purpose of the Study:
- To critically review the literature on the impact of CMIN in urology.
- To identify and evaluate prophylactic measures against CMIN in urological patients.
Main Methods:
- A comprehensive literature search was conducted using MEDLINE/PubMed, EMBASE, and Cochrane Library databases.
- Articles published between 1971 and 2006 concerning contrast medium use in urology and CMIN were systematically reviewed.
Main Results:
- Numerous urological conditions necessitate imaging with contrast media.
- Understanding CMIN risk factors and prevention strategies is crucial for urological patients.
- Effective prophylaxis involves discontinuing nephrotoxic drugs and implementing periprocedural hydration protocols.
Conclusions:
- The established approach for CMIN recognition and prevention should be integrated into urological practice.
- There is a lack of definitive evidence-based data for CMIN management specifically in urological patients.
- Further controlled trials are essential to determine the incidence of CMIN in uroradiology procedures.
Purpose:
Contrast medium induced nephropathy is the third cause of in-hospital acute renal failure. The first studies in this area were done with reference to urological practice only. Although various guidelines on the management of contrast medium induced nephropathy were provided by the European Society of Urogenital Radiology, more recently many investigators have focused their attention on contrast medium use in interventional vascular radiology and cardiology. We critically reviewed the literature to clarify the impact of contrast medium induced nephropathy in urology and the possible prophylactic measures against it.
Materials And Methods:
A MEDLINE/PubMed, EMBASE and Cochrane Library search for 1971 to 2006 was performed. All articles related to the use of contrast medium in urological practice and contrast medium induced nephropathy were reviewed.
Results:
Many pathological conditions frequently seen by urologists are diagnosed by imaging requiring contrast medium. A basic understanding of the risk factors for contrast medium induced nephropathy and the strategies for its prevention are useful to prepare urological patients for these procedures. Prophylaxis includes the discontinuation of potentially nephrotoxic drugs and the use of protocols for periprocedural hydration.
Conclusions:
The general approach to the recognition and prevention of contrast medium induced nephropathy in patients at risk should be extended to urological clinical practice since no definitive evidence based data are available regarding contrast medium induced nephropathy management in urological patients. Moreover, these patients can frequently present with the most significant risk factor for contrast medium mediated kidney damage, that is preexisting acute or chronic renal failure. Controlled trials are needed to establish the incidence of contrast medium induced nephropathy in diagnostic or interventional procedures in uroradiology.
Related Concept Videos
Radiological Investigation I: X-ray and CT
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies III: Computed Tomography
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Urinary Tract Calculi III: Medical Management
Imaging Studies VII: Vascular Imaging

